Who Supplies Levamisole? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Levamisole exports, with 72+ registered manufacturers shipping to buyers across 39+ countries — yet a handful of companies dominate the shipments. COMBITIC GLOBAL CAPLET PRIVATE LIMITED holds the largest share at 12.8% (export value: $341.0K). Close behind, LYKA BDR INTERNATIONAL LIMITED (10.7%, $283.5K). LYKA LABS LIMITED (4.9%, $130.5K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Levamisole? Top Manufacturers & Their Buyers
Flow of Levamisole from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Levamisole Supplier Network — Key Market Intelligence
The Levamisole export market from India is led by COMBITIC GLOBAL CAPLET PRIVATE LIMITED, which alone commands a 12.8% share, shipping $341.0K worth of product across 25 shipments. The second-largest exporter, LYKA BDR INTERNATIONAL LIMITED, contributes $283.5K (10.7%) to the overall market. Combined, the top two suppliers alone account for 23.5% of all Levamisole exports, indicating a relatively concentrated supply base.
Across all 72 tracked manufacturers, the total Levamisole export value stands at $2.7M from 325 shipments. The market average shipment value is $8.2K. The single largest buyer relationship in terms of trade value is LLC SMART PHARMO, receiving $221.1K worth of product.
The combined buyer network spans 8 named purchasing companies, including LLC SMART PHARMO, BIOMEDIKAL LLC, SHAMS NOORI PHARMA T, KHAN SEHAT LTD, DARVET FOR TRADING & INVESTMENT CO and 3 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1COMBITIC GLOBAL CAPLET PRIVATE LIMITED
COMBITIC GLOBAL CAPLET PRIVATE LIMITED is the first-largest Levamisole exporter from India, with a market share of 12.8% and a total export value of $341.0K across 25 shipments. Their average shipment value of $13.6K is above the market average of $8.2K, suggesting premium or bulk contract pricing.
COMBITIC GLOBAL CAPLET PRIVATE LIMITED serves 4 named buyers in our database. LLC SMART PHARMO is the dominant customer, accounting for 64.8% of this supplier's tracked business. Top customers include:
• LLC SMART PHARMO — $221.1K across 16 shipments (64.8% of this supplier's total exports)
• BIOMEDIKAL LLC — $113.8K across 8 shipments (33.4% of this supplier's total exports)
• SHAMS NOORI PHARMA T — $6.0K across 0 shipments (1.7% of this supplier's total exports)
• KHAN SEHAT LTD — $86 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: COMBITIC GLOBAL CAPLET PRIVATE LIMITED's per-shipment value of $13.6K is 67% above the market average of $8.2K, consistent with large-order contracts or value-added formulations.
2LYKA BDR INTERNATIONAL LIMITED
LYKA BDR INTERNATIONAL LIMITED is the second-largest Levamisole exporter from India, with a market share of 10.7% and a total export value of $283.5K across 11 shipments. Their average shipment value of $25.8K is above the market average of $8.2K, suggesting premium or bulk contract pricing.
LYKA BDR INTERNATIONAL LIMITED serves 2 named buyers in our database. DARVET FOR TRADING & INVESTMENT CO is the dominant customer, accounting for 75.0% of this supplier's tracked business. Top customers include:
• DARVET FOR TRADING & INVESTMENT CO — $212.5K across 8 shipments (75.0% of this supplier's total exports)
• DARVET FOR TRADING & INVESTMENT CO — $71.0K across 3 shipments (25.0% of this supplier's total exports)
Key Insight: LYKA BDR INTERNATIONAL LIMITED's per-shipment value of $25.8K is 215% above the market average of $8.2K, consistent with large-order contracts or value-added formulations.
3LYKA LABS LIMITED
LYKA LABS LIMITED is the third-largest Levamisole exporter from India, with a market share of 4.9% and a total export value of $130.5K across 3 shipments. Their average shipment value of $43.5K is above the market average of $8.2K, suggesting premium or bulk contract pricing.
LYKA LABS LIMITED serves 1 named buyer in our database. HNL GENERAL TRADING LLC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• HNL GENERAL TRADING LLC — $130.5K across 3 shipments (100.0% of this supplier's total exports)
Key Insight: LYKA LABS LIMITED's per-shipment value of $43.5K is 431% above the market average of $8.2K, consistent with large-order contracts or value-added formulations.
4DOSCH PHARMACEUTICALS PRIVATE LIMITED
DOSCH PHARMACEUTICALS PRIVATE LIMITED is the fourth-largest Levamisole exporter from India, with a market share of 4.6% and a total export value of $122.1K across 24 shipments. Their average shipment value of $5.1K is below the market average of $8.2K, reflecting a high-volume, competitive pricing strategy.
DOSCH PHARMACEUTICALS PRIVATE LIMITED serves 3 named buyers in our database. NA is the dominant customer, accounting for 68.3% of this supplier's tracked business. Top customers include:
• NA — $83.3K across 16 shipments (68.3% of this supplier's total exports)
• TO THE ORDER — $36.9K across 7 shipments (30.2% of this supplier's total exports)
• TO THE ORDER — $1.8K across 0 shipments (1.5% of this supplier's total exports)
Key Insight: DOSCH PHARMACEUTICALS PRIVATE LIMITED operates with high shipment frequency (24 shipments) at a per-shipment value of $5.1K, indicating a broad distribution network with many smaller, regular orders.
5PRASHI PHARMA PRIVATE LIMITED
PRASHI PHARMA PRIVATE LIMITED is the fifth-largest Levamisole exporter from India, with a market share of 3.7% and a total export value of $99.2K across 15 shipments. Their average shipment value of $6.6K is below the market average of $8.2K, reflecting a high-volume, competitive pricing strategy.
PRASHI PHARMA PRIVATE LIMITED serves 1 named buyer in our database. STE PRINCE PHARMA SARL is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• STE PRINCE PHARMA SARL — $99.2K across 15 shipments (100.0% of this supplier's total exports)
Key Insight: PRASHI PHARMA PRIVATE LIMITED operates with high shipment frequency (15 shipments) at a per-shipment value of $6.6K, indicating a broad distribution network with many smaller, regular orders.
6DIPS BIOSCIENCE PRIVATE LIMITED
DIPS BIOSCIENCE PRIVATE LIMITED is the fifth-largest Levamisole exporter from India, with a market share of 3.6% and a total export value of $95.5K across 4 shipments. Their average shipment value of $23.9K is above the market average of $8.2K, suggesting premium or bulk contract pricing.
DIPS BIOSCIENCE PRIVATE LIMITED serves 2 named buyers in our database. M S is the dominant customer, accounting for 81.7% of this supplier's tracked business. Top customers include:
• M S — $78.0K across 3 shipments (81.7% of this supplier's total exports)
• TO THE ORDER — $17.5K across 1 shipments (18.3% of this supplier's total exports)
Key Insight: DIPS BIOSCIENCE PRIVATE LIMITED's per-shipment value of $23.9K is 191% above the market average of $8.2K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Levamisole Flows
Once Levamisole leaves the manufacturing plants of companies like COMBITIC GLOBAL CAPLET PRIVATE LIMITED and LYKA BDR INTERNATIONAL LIMITED, it travels to 5 destination markets with a combined import value of $2.7M. Sudan absorbs the largest share at 39.3% ($1.0M), followed by Congo Dr (14.9%) and Uzbekistan (14.0%).
In Sudan — the top destination — named importers include HNL GENERAL TRADING LLC, DARVET FOR TRADING & INVESTMENT CO, DARVET FOR TRADING INVESTMENT CO. In Congo Dr, key buyers are STE PRINCE PHARMA SARL, MEDICO PLUS.
This geographic spread reflects Levamisole's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Levamisole Go? Top Importing Countries & Their Buyers
Trade flow of Levamisole exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Sudan
Sudan ranks as the first-largest destination for Levamisole imports from India, with a total trade value of $1.0M across 14 shipments — representing a 39.3% share of all Levamisole exports. The average shipment value of $74.7K is above the global average of $8.2K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Levamisole importers in Sudan: HNL GENERAL TRADING LLC is the largest buyer, accounting for 72.9% ($762.3K) of this market's total imports.
• HNL GENERAL TRADING LLC — $762.3K (72.9% of Sudan's total)
• DARVET FOR TRADING & INVESTMENT CO — $212.5K (20.3% of Sudan's total)
• DARVET FOR TRADING INVESTMENT CO — $71.0K (6.8% of Sudan's total)
Key Insight: Sudan's per-shipment average of $74.7K (812% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sudan is a key market for Levamisole imports from India.
2Congo Dr
Congo Dr ranks as the second-largest destination for Levamisole imports from India, with a total trade value of $397.6K across 20 shipments — representing a 14.9% share of all Levamisole exports. The average shipment value of $19.9K is above the global average of $8.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Levamisole importers in Congo Dr: STE PRINCE PHARMA SARL is the largest buyer, accounting for 47.7% ($189.5K) of this market's total imports.
• STE PRINCE PHARMA SARL — $189.5K (47.7% of Congo Dr's total)
• MEDICO PLUS — $29.0K (7.3% of Congo Dr's total)
Key Insight: Congo Dr's per-shipment average of $19.9K (143% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Congo Dr is a key market for Levamisole imports from India.
3Uzbekistan
Uzbekistan ranks as the third-largest destination for Levamisole imports from India, with a total trade value of $372.7K across 14 shipments — representing a 14.0% share of all Levamisole exports. The average shipment value of $26.6K is above the global average of $8.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Levamisole importers in Uzbekistan: LLC SMART PHARMO is the largest buyer, accounting for 59.3% ($221.1K) of this market's total imports.
• LLC SMART PHARMO — $221.1K (59.3% of Uzbekistan's total)
• BIOMEDIKAL LLC — $132.5K (35.6% of Uzbekistan's total)
Key Insight: Uzbekistan's per-shipment average of $26.6K (225% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Uzbekistan is a key market for Levamisole imports from India.
4United Kingdom
United Kingdom ranks as the fourth-largest destination for Levamisole imports from India, with a total trade value of $95.5K across 0 shipments — representing a 3.6% share of all Levamisole exports. The average shipment value of $95.5K is above the global average of $8.2K, indicating high-value procurement contracts or branded formulations.
Key Insight: United Kingdom's per-shipment average of $95.5K (1066% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Kingdom is a key market for Levamisole imports from India.
5Chad
Chad ranks as the fifth-largest destination for Levamisole imports from India, with a total trade value of $82.1K across 2 shipments — representing a 3.1% share of all Levamisole exports. The average shipment value of $41.0K is above the global average of $8.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Levamisole importers in Chad: KEBIRVET SARL is the largest buyer, accounting for 43.9% ($36.0K) of this market's total imports.
• KEBIRVET SARL — $36.0K (43.9% of Chad's total)
Key Insight: Chad's per-shipment average of $41.0K (401% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Chad is a key market for Levamisole imports from India.
People Also Ask — Levamisole Supplier & Trade Network
Who are the top suppliers of Levamisole from India?+
Which companies buy Levamisole from Indian manufacturers?+
Where does Levamisole exported from India go?+
What is the market share of the top Levamisole supplier from India?+
What is the average shipment value for Levamisole exports from India?+
Is Levamisole manufactured in India and exported globally?+
Which country imports the most Levamisole from India?+
Who are the buyers of Levamisole in Congo Dr?+
How concentrated is the Levamisole supplier market in India?+
How do I find verified buyers for Levamisole in specific countries?+
Levamisole Trade Network — Key Takeaways
- 1COMBITIC GLOBAL CAPLET PRIVATE LIMITED is India's dominant Levamisole exporter with a 12.8% market share and $341.0K in total exports — making it the single most important sourcing entity in this market.
- 2The top 72 suppliers collectively account for 40.3% of all tracked Levamisole exports, with a combined trade value of $2.7M.
- 3Sudan is the largest destination market, absorbing 39.3% of India's Levamisole exports ($1.0M). Congo Dr (14.9%) and Uzbekistan (14.0%) follow.
- 4With 325 total shipments averaging $8.2K each, the Levamisole export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include LLC SMART PHARMO, BIOMEDIKAL LLC, DARVET FOR TRADING & INVESTMENT CO, DARVET FOR TRADING & INVESTMENT CO — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 4 customers
6 suppliers → 39 countries
Network value: $2.7M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Levamisole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Levamisole.
- 2.Flow Mapping: 72 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 325 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 39 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
325 Verified Shipments
72 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists